Targeting clonal evolution therapeutically is an area of active research. Strategies such as combination therapies aim to target multiple clones simultaneously, reducing the likelihood of resistance. Adaptive therapy, which adjusts treatment based on clonal response, is another approach being explored. Immunotherapies that enhance the immune system's ability to recognize and eliminate diverse clones also hold promise.
